High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$5.0M
$5,000,006
Total Sells (Filtered)
$12K
$12,869
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KLRS
S
Kalaris Therapeutics, Inc.
Hagen Brett R
• Officer • Chief Accounting Officer
Discretionary Sell
2026-03-20
$12,869
|
||||||
| KLRS |
Kalaris Therapeutics, Inc.
|
Officer • Chief Accounting Officer
Discretionary Sell
|
2026-03-20 | $12,869 | S | Form 4 |
|
KLRS
P
Kalaris Therapeutics, Inc.
AKKARAJU SRINIVAS
• Director
Discretionary BuyΔOwn +32.0%
2025-12-18
$5,000,006Whale
|
||||||
| KLRS |
Kalaris Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +32.0%
|
2025-12-18 | $5,000,006Whale | P | Form 4 |